0001700449-18-000001.txt : 20180404 0001700449-18-000001.hdr.sgml : 20180404 20180404131449 ACCESSION NUMBER: 0001700449-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180404 DATE AS OF CHANGE: 20180404 EFFECTIVENESS DATE: 20180404 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Arix Bioscience plc CENTRAL INDEX KEY: 0001700449 IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-309307 FILM NUMBER: 18736547 BUSINESS ADDRESS: STREET 1: 20 BERKELEY SQUARE CITY: LONDON STATE: X0 ZIP: W1J 6EQ BUSINESS PHONE: 44(0)20 7290 1050 MAIL ADDRESS: STREET 1: 20 BERKELEY SQUARE CITY: LONDON STATE: X0 ZIP: W1J 6EQ D 1 primary_doc.xml X0708 D LIVE 0001700449 Arix Bioscience plc 20 BERKELEY SQUARE LONDON X0 UNITED KINGDOM W1J 6EQ 44(0)20 7290 1050 UNITED KINGDOM Arix Bioscience Limited Perceptive Bioscience Investments Limited None Other Public limited company in the United Kingdom true 2015 JOSEPH ANDERSON 20 BERKELEY SQUARE LONDON X0 UNITED KINGDOM W1J 6EQ Executive Officer Director CHRISTOPHER EVANS 20 BERKELEY SQUARE LONDON X0 UNITED KINGDOM W1J 6EQ Executive Officer Director JONATHAN PEACOCK 20 BERKELEY SQUARE LONDON X0 UNITED KINGDOM W1J 6EQ Executive Officer Director JOHN HUTTON OF FURNESS 20 BERKELEY SQUARE LONDON X0 UNITED KINGDOM W1J 6EQ Director JAMES RAWLINGSON 20 BERKELEY SQUARE LONDON X0 UNITED KINGDOM W1J 6EQ Executive Officer Director DAVID U'PRICHARD 20 BERKELEY SQUARE LONDON X0 UNITED KINGDOM W1J 6EQ Director FRANZ HUMER 20 BERKELEY SQUARE LONDON X0 UNITED KINGDOM W1J 6EQ Director TREVOR JONES 20 BERKELEY SQUARE LONDON X0 UNITED KINGDOM W1J 6EQ Director MEGHAN MAIR FITZGERALD 20 BERKELEY SQUARE LONDON X0 UNITED KINGDOM W1J 6EQ Director GILES KERR 20 BERKELEY SQUARE LONDON X0 UNITED KINGDOM W1J 6EQ Director Other Health Care Decline to Disclose 06b false 2018-03-20 false true false 0 JEFFRIES INTERNATIONAL LIMITED None JEFFRIES & COMPANY, INC. 2347 68 UPPER THAMES STREET LONDON X0 UNITED KINGDOM EC4V 2AF CA CALIFORNIA IL ILLINOIS MA MASSACHUSETTS NJ NEW JERSEY true STIFEL NICOLAUS EUROPE LIMITED None STIFEL, NICOLAUS & COMPANY, INCORPORATED 793 150 CHEAPSIDE LONDON X0 UNITED KINGDOM EC2V 6ET IL ILLINOIS MA MASSACHUSETTS NJ NEW JERSEY true LIFESCI CAPITAL LLC 168404 None None 250 WEST 55TH STREET SUITE 16B NEW YORK NY NEW YORK 10019 CA CALIFORNIA IL ILLINOIS MA MASSACHUSETTS NJ NEW JERSEY false 121778626 21438354 100340272 Offering was conducted as a public offering in the U.K. and available to U.S. investors by private placement. Offering raised approx. $121,778,626 in total, with approx. $21,438,354 raised in the U.S. and approx. $100,340,272 raised outside the U.S. false 5 379127 0 Sales commissions were paid to Jeffries, Stifel and LifeSci in the amounts of approx. $279,522, $65,139, and $34,466, respectively. 0 false Arix Bioscience plc /s/ James Rawlingson James Rawlingson Director 2018-04-04